Boston Scientific Corp
BSX
$104.61+0.32 (+0.31%)
Jun 26, 2025, 12:38 PM
Financials
| 52Week High | 107.17 | 52Week Low | 71.88 |
| Beta | 0.67 | Current Ratio Annual | 1.08 |
| Current Ratio Quarterly | 1.45 | Gross Margin TTM | 68.65 |
| Market Cap | 154.28B | Net Profit Margin TTM | 11.58 |
| Operating Margin TTM | 16.23 | Price To Book | 6.95 |
| Price To Earnings TTM | 75.89 | Price To Free Cash Flow TTM | 51.19 |
| Price To Sales TTM | 8.79 | Quick Ratio Annual | 0.59 |
| Quick Ratio Quarterly | 0.83 | Return On Assets TTM | 5.26 |
| Return On Equity TTM | 9.56 | Return On Investment TTM | 6.32 |
| Revenue Growth3Y | 12.10 | Revenue Growth5Y | 9.30 |
| Revenue Growth Quarterly Yoy | 20.93 | Revenue Growth TTMYoy | 19.35 |
| Revenue Per Share TTM | 11.76 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 1499 | 6 | 1 | 7 | 18 | 9 | 1.35B | $114.96B |
| Mar 31, 2025 | 1554 | 200 | 131 | 628 | 525 | 174 | 1.33B | $126.49B |
| Change | 55(4%) | 194(3233%) | 130(13000%) | 621(8871%) | 507(2817%) | 165(1833%) | 21.14M(2%) | $11.53B(10%) |